Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Liu H et al. – The results of this 4–week, double–blind, randomized trial have demonstrated that in Chinese male hypertensive patients with LUTS, low–dose Amlodipine plus terazosin therapy appears to be a safe and effective combination therapy to control both conditions, especially for those with predominant overactive bladder symptoms.

Related Articles

Alpha-1 adrenoceptor stimulation triggers axon-reflex vasodilatation in human skin
Autonomic Neuroscience, 11/11/09    Relevance Score: 84%

Today in Clinical Pharmacology...keeping you current

Long-term Clinical Outcomes of a Phase I Trial of Intravesical Docetaxel in the Management of Non-Muscle-Invasive Bladder Cancer Refractory to Standard Intravesical Therapy
Urology, 12/02/09

High-grade prostate cancer and finasteride
BJU International, 12/02/09

Reboxetine in therapy-resistant enuresis: A retrospective evaluation
Scandinavian Journal of Urology and Nephrology, 12/01/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address